New study explores urinary management in people with spinal cord injury
Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.
Read moreAll news
Rethink Medical participates in WHX Dubai 2026
Rethink Medical participated in WHX Dubai 2026 (9–12 February 2026), one of the major international meeting points for the healthcare and medical-technology sector.
The visit provided an opportunity to present T-Control® in an international environment, meet potential partners and explore opportunities for the company's international development.
Rethink Medical participated as part of the Canary Islands healthcare delegation supported by PROEXCA, alongside other companies from the region.
More news
Rethink Medical presents T-Control® at the 48th Spanish Neuroscience Nursing Congress
Rethink Medical participated in the 48th Congress of the Spanish Neuroscience Nursing Association, sharing the journey from identifying an unmet need in clinical practice to developing a regulated medical device.
Read more
Rethink Medical reaches the minimum target of its 2026 investment round
Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.
Read more